We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

Novonesis, a world-leading biosolutions company, recognizes the importance of the National Security Commission on Emerging Biotechnology (NSCEB) report as a pivotal milestone in charting a bold path ...

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ to discuss investing in biotech and the oversaturation in the sector. He said that looking at ...

The former presidential hopeful shared an X post on Friday, stating he would "unleash an economic boom in Ohio like we ...

Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

Those who position early won’t just reap financial returns but could shape the future of ageing itself. Read more at ...

Explore biomanufacturing with Dr. Doug Friedman and discover how it transforms the global economy and job markets.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

GMO 2.0 is happening whether we want it or not—let’s make sure it’s a power for good. With genetically modified organisms (GMOs), there’s no putting the genie back in the bottle. Since their ...

Executive leadership conducted partial equity sales, contributing to minor insider activity.,Revolution Medicines maintains a focus o... "Kalkine Media dolor sit amet, consectetur adipiscing elit, sed ...